Evoke Pharma Correlations
| EVOK Stock | USD 4.52 0.13 2.96% |
A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evoke Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evoke Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Evoke Pharma Correlation With Market
Significant diversification
The correlation between Evoke Pharma and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Evoke Pharma and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Evoke Stock
| 0.66 | BA | Boeing Earnings Call This Week | PairCorr |
| 0.69 | DD | Dupont De Nemours Earnings Call This Week | PairCorr |
| 0.61 | MMM | 3M Company Sell-off Trend | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Evoke Stock performing well and Evoke Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Evoke Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| GHSI | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TKNO | 2.55 | (0.59) | 0.00 | (0.26) | 0.00 | 6.34 | 16.58 | |||
| PTPI | 11.71 | (5.64) | 0.00 | (0.40) | 0.00 | 14.29 | 210.34 | |||
| PULM | 3.72 | 0.16 | 0.02 | 0.45 | 3.66 | 11.40 | 27.23 | |||
| GYRE | 4.41 | (0.44) | (0.02) | 0.01 | 6.42 | 8.10 | 36.21 |
Evoke Pharma Corporate Management
| Mark CPA | Chief Officer | Profile | |
| DMD MD | Chief Officer | Profile | |
| Christopher Quesenberry | Chief Gimoti | Profile | |
| Marilyn Carlson | Chief Medical Officer | Profile |